Passive immunity against measles during the first 8 months of life of infants born to vaccinated mothers or to mothers who sustained measles. 1997

G De Serres, and J R Joly, and M Fauvel, and F Meyer, and B Mâsse, and N Boulianne
Centre de Santé Publique de Québec, Beauport, Canada.

Neutralizing antibody titers of 47 infants whose mothers sustained measles (measles group) and 70 whose mothers were vaccinated (vaccine group) were compared at birth, 4 and 8 months of age. All children had antibodies at birth and 88% at 4 months. At 8 months, 49% had antibodies in the measles group and 15% in the vaccine group (P < 0.001). The geometric mean titers were significantly lower in the vaccine group than in the measles group and the difference corresponded to the antibody loss occurring in only 1.5 months of life. This small difference may reflect past exposure to wild virus of many vaccinated mothers.

UI MeSH Term Description Entries
D007112 Immunity, Maternally-Acquired Resistance to a disease-causing agent induced by the introduction of maternal immunity into the fetus by transplacental transfer or into the neonate through colostrum and milk. Fetal Immunity, Maternally-Acquired,Maternally-Acquired Immunity,Neonatal Immunity, Maternally-Acquired,Immunity, Maternally Acquired,Fetal Immunities, Maternally-Acquired,Fetal Immunity, Maternally Acquired,Immunity, Maternally-Acquired Fetal,Immunity, Maternally-Acquired Neonatal,Maternally Acquired Immunities,Maternally Acquired Immunity,Maternally-Acquired Fetal Immunities,Maternally-Acquired Fetal Immunity,Maternally-Acquired Immunities,Maternally-Acquired Neonatal Immunities,Maternally-Acquired Neonatal Immunity,Neonatal Immunities, Maternally-Acquired,Neonatal Immunity, Maternally Acquired
D007223 Infant A child between 1 and 23 months of age. Infants
D008457 Measles A highly contagious infectious disease caused by MORBILLIVIRUS, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the MONONUCLEAR PHAGOCYTE SYSTEM. Rubeola
D008458 Measles Vaccine A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed) Vaccine, Measles
D009035 Mothers Female parents, human or animal. Mothers' Clubs,Club, Mothers',Clubs, Mothers',Mother,Mother Clubs,Mother's Clubs,Mothers Clubs,Mothers' Club
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies

Related Publications

G De Serres, and J R Joly, and M Fauvel, and F Meyer, and B Mâsse, and N Boulianne
December 2003, Medical science monitor : international medical journal of experimental and clinical research,
G De Serres, and J R Joly, and M Fauvel, and F Meyer, and B Mâsse, and N Boulianne
February 2017, Sleep medicine,
G De Serres, and J R Joly, and M Fauvel, and F Meyer, and B Mâsse, and N Boulianne
January 1999, Scandinavian journal of infectious diseases,
G De Serres, and J R Joly, and M Fauvel, and F Meyer, and B Mâsse, and N Boulianne
November 1999, Acta paediatrica (Oslo, Norway : 1992),
G De Serres, and J R Joly, and M Fauvel, and F Meyer, and B Mâsse, and N Boulianne
December 1997, Journal of paediatrics and child health,
G De Serres, and J R Joly, and M Fauvel, and F Meyer, and B Mâsse, and N Boulianne
April 1998, Acta paediatrica (Oslo, Norway : 1992),
G De Serres, and J R Joly, and M Fauvel, and F Meyer, and B Mâsse, and N Boulianne
January 1984, Southern medical journal,
G De Serres, and J R Joly, and M Fauvel, and F Meyer, and B Mâsse, and N Boulianne
February 1983, Pediatriia,
G De Serres, and J R Joly, and M Fauvel, and F Meyer, and B Mâsse, and N Boulianne
December 2010, Health technology assessment (Winchester, England),
G De Serres, and J R Joly, and M Fauvel, and F Meyer, and B Mâsse, and N Boulianne
August 1997, Acta paediatrica (Oslo, Norway : 1992),
Copied contents to your clipboard!